JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

Anesth Analg 2008; 106:480-485
© 2008 International Anesthesia Research Society
doi: 10.1213/ane.0b013e318160648b
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Puana, R.
Right arrow Articles by Childs, E. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Puana, R.
Right arrow Articles by Childs, E. W.
Related Collections
Right arrow Mechanisms
Right arrow Preclinical Pharmacology
Right arrow Pharmacology

ANESTHETIC PHARMACOLOGY

Morphine Attenuates Microvascular Hyperpermeability via a Protein Kinase A-Dependent Pathway

Rudolph Puana, MD*, Russell K. McAllister, MD*{dagger}, Felicia A. Hunter, BS{dagger}, Julie Warden, MD*{dagger}, and Ed W. Childs, MD{dagger}

From the Departments *Anesthesiology and {dagger}Surgery, Scott and White Clinic and Memorial Hospital, Scott, Sherwood and Brindley Foundation, Texas A&M Health Science Center College of Medicine, Temple, Texas.

Address correspondence and reprint requests to Ed Childs, MD, Associate Professor of Surgery, Scott and White Memorial Hospital, 2401 S. 31st St., Temple, TX 76508. Address e-mail to echilds{at}swmail.sw.org.

BACKGROUND: A recently published study from our laboratory demonstrated that morphine sulfate (MS) attenuates microvascular hyperpermeability after hemorrhagic shock in rats.

MS binds to the µ receptors located on the surface of endothelial cells. Activation of the endothelial cell µ receptors has been shown by several investigators to stimulate adenylate cyclase. We hypothesize that MS binding to the µ receptor on endothelial cells increases cyclic adenosine monophosphate via adenylate cyclase activation. Cyclic adenosine monophosphate inhibits the phosphoinositide/MAP kinase hyperpermeability pathway via the protein kinase A (PKA)-dependent inhibition of Raf-1.

METHODS: Studies were conducted in five groups of urethane-anesthetized Sprague-Dawley rats: Group 1—control group, Group 2—a non–receptor-blocking adenylate cyclase inhibitor: SQ22536, at 100 µg/kg (n = 5), Group 3—a PKA inhibitor: H89, at 10 µg/kg, Group 4—a morphine sulfate (10 µg/kg) and PKA inhibitor group, and Group 5—an adenylate cyclase inhibited and morphine (10 µg/kg) group. Intravital microscopy in mesenteric postcapillary venules and rat lung microvascular endothelial cell monolayers were used to measure permeability.

RESULTS: Adenylate cyclase and PKA inhibition resulted in vascular hyperpermeability.

CONCLUSION: Our data demonstrated an increase in vascular hyperpermeability after inhibition of adenylate cyclase via SQ22536, a nonreceptor inhibitor. This increase in hyperpermeability was attenuated when treated with MS. Morphine did not attenuate hyperpermeability after blockage following PKA with H89 suggesting the action of MS is upstream of PKA and PKA dependent.






Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2008 by the International Anesthesia Research Society.